Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

PARAINFLUENZA VIRUS - ANVISA Registration 80254180239

Access comprehensive regulatory information for PARAINFLUENZA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180239 and manufactured by REMEL INC.. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including R-BIOPHARMA AG, OXOID (ELY) LIMITED, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
4 Competitors
5 Recent Registrations
80254180239
Registration Details
ANVISA Registration Number: 80254180239
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

XPECT FLU A/B
Risk Class II

Registration Details

80254180239

25351151355201701

04930429000139

Company Information

REMEL INC.
United States of America
PT: ESTADOS UNIDOS DA AMร‰RICA

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01